5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 20.94▼ | 20.94▼ | 20.98▼ | 22.24▼ | 23.16▼ |
MA10 | 20.90▼ | 21.04▼ | 21.37▼ | 23.22▼ | 21.83▼ |
MA20 | 20.92▼ | 21.45▼ | 21.96▼ | 23.43▼ | 21.19▼ |
MA50 | 21.02▼ | 22.15▼ | 22.65▼ | 21.61▼ | 24.51▼ |
MA100 | 21.46▼ | 22.84▼ | 23.48▼ | 21.58▼ | N/A |
MA200 | 22.01▼ | 23.51▼ | 22.64▼ | 24.61▼ | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.010▲ | -0.027▼ | -0.096▼ | -0.445▼ | 0.404▲ |
RSI | 43.074▼ | 29.094▼ | 24.723▼ | 39.758▼ | 45.812▼ |
STOCH | 73.657 | 24.014 | 11.992▼ | 16.736▼ | 75.118 |
WILL %R | -53.333 | -86.742▼ | -91.071▼ | -95.842▼ | -47.173 |
CCI | -48.028 | -74.381 | -99.964 | -173.157▼ | 30.783 |
Tuesday, July 01, 2025 01:05 PM
ArriVent BioPharma, Inc. (“ArriVent”) (Nasdaq: AVBP), a clinical-stage company dedicated to accelerating the global development of innovative biopharmaceutical therapeutics, today announced that it ...
|
Monday, June 30, 2025 11:05 PM
Shares of ArriVent BioPharma, Inc. (NASDAQ:AVBP – Get Free Report) have been given a consensus rating of “Buy” by the seven ratings firms that are covering the stock, MarketBeat.com reports. Six ...
|
Monday, June 23, 2025 09:00 PM
ArriVent BioPharma, Inc. (Nasdaq: AVBP) has shared encouraging interim results from its Phase 1b FURTHER trial, which investigates firmonertinib as a first-line monotherapy for non-small cell lung ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
01/07/25 | 21.63 | 22.065 | 20.68 | 20.89 | 415,100 |
30/06/25 | 22.87 | 23.165 | 21.68 | 21.77 | 305,800 |
27/06/25 | 22.87 | 23.2648 | 22.305 | 22.91 | 591,465 |
26/06/25 | 22.82 | 23.045 | 22.12 | 22.81 | 284,000 |
25/06/25 | 23.30 | 23.44 | 22.525 | 22.80 | 418,100 |
24/06/25 | 24.03 | 24.03 | 22.71 | 23.11 | 935,700 |
23/06/25 | 24.705 | 25.73 | 22.04 | 22.80 | 1,350,700 |
20/06/25 | 25.10 | 25.58 | 24.55 | 25.22 | 441,500 |
18/06/25 | 24.95 | 25.625 | 24.61 | 24.89 | 219,085 |
17/06/25 | 25.28 | 25.70 | 24.0559 | 24.98 | 347,325 |
|
|
||||
|
|
||||
|
|